MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
ReferenceBot (talk | contribs)
Changed an Item
 
(3 intermediate revisions by 3 users not shown)
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q52211232 / rank
 
Normal rank
Property / cites work
 
Property / cites work: One-Sample Multiple Testing Procedure for Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bivariate Sequential Designs for Phase II Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs for Group Sequential Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Bayesian Approach to the Design of Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Practical Bayesian Guidelines for Phase IIB Clinical Trials / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 17:13, 30 May 2024

scientific article; zbMATH DE number 1525738
Language Label Description Also known as
English
MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
scientific article; zbMATH DE number 1525738

    Statements

    MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    27 February 2001
    0 references
    0 references
    multiple-stage stopping rule
    0 references
    multivariate endpoint
    0 references
    missing data
    0 references
    clinical trial
    0 references
    oncology
    0 references
    0 references